TRDA EPS Estimates
Entrada Therapeutics, Inc.
$4.55
-$0.31(-6.38%)
37
Overall
60
Value
18
Tech
34
Quality
Market Cap
$177.16M
Volume
740.06K
52W Range
$5.15 - $16.45
Target Price
$19.00
TRDA EPS estimates: the consensus estimate for Entrada Therapeutics, Inc.'s current fiscal year is -$4.03 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
TRDA EPS Estimates
- EPS estimate, current quarter
- $-0.98
- EPS estimate, next quarter
- $-1.01
- EPS estimate, current year
- $-4.03
- EPS estimate, next year
- $-3.52
- EPS growth, 3-year
- -4.74%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.47 |
| 2024 | $1.76 |
| 2023 | $-0.20 |
| 2022 | $-3.02 |
| 2021 | $-8.16 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRDA | $4.55 | -6.4% | 740.06K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Entrada Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW